PULSE BIOSCIENCES, INC. — Director's Dealing 2017

May 11, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-05-10

Reporting Person: Greenberg Robert J. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-10	Common Stock	M	25000	$2.67	Acquired	25000	Direct
2017-05-10	Common Stock	S	22180	$21.03	Disposed	2820	Direct
2017-05-10	Common Stock	S	2820	$21.867	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-10	Stock Option (right to buy)	$2.67	M	25000	Disposed	2020-06-01	Common Stock (25000)	Direct

Footnotes

F1: This is the weighted average purchase price of the shares, which ranged from $20.62 to $21.57 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F2: This is the weighted average purchase price of the shares, which ranged from $21.77 to $21.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F3: The shares subject to the option will vest in equal quarterly installments over a three year period that commenced on June 1, 2015 and will end on Marcn 1, 2018, subject to the Reporting Person's continued service through each vesting date.